The Application Value of Spectral CT in the Accurate Staging of Colorectal Cancer
Not Applicable
Not yet recruiting
- Conditions
- Colorectal Cancer
- Registration Number
- NCT06977373
- Lead Sponsor
- Yunnan Cancer Hospital
- Brief Summary
Spectral CT was used to prospectively collect medical images and clinical data related to colorectal cancer, evaluate the effect of image quality in the diagnosis of colorectal cancer, and evaluate the application value in the accurate staging of colorectal cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- Undergo a contrast-enhanced Quark Spectral CT scan of the lower abdomen/pelvis within 1 week before treatment.
- Age > 18 years.
- Patients suspected of having colorectal cancer.
- Patients who have signed the informed consent form.
Exclusion Criteria
- Severe cardiac, pulmonary, or renal insufficiency.
- Allergy to iodine-based contrast agents.
- Inability to cooperate with the CT examination.
- Poor image quality of the Quark Spectral CT scan.
- Women who are pregnant or breastfeeding.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Pathological TNM staging 1 day Pathological examination information: The pathology results using surgery/biopsy data are the gold standard, and the depth of tumor invasion, lymph node metastasis, and distant metastasis are recorded
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Yunnan Cancer Hospital
🇨🇳Kunming, City, China